Seizure	seizure	O	DISEASE	OTHERS	I
resulting	resulting	O	O	O	O
from	from	O	O	O	O
a	a	O	O	O	O
venlafaxine	venlafaxine	CHEMICALS	O	OTHERS	I
overdose	overdose	O	DISEASE	OTHERS	I
.	.	O	O	O	O

OBJECTIVE	objective	O	O	O	O
:	:	O	O	O	O
To	to	O	O	O	O
report	report	O	O	O	O
a	a	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
venlafaxine	venlafaxine	CHEMICALS	O	OTHERS	I
overdose	overdose	O	DISEASE	OTHERS	I
.	.	O	O	O	O

CASE	case	O	O	O	O
SUMMARY	summary	O	O	O	O
:	:	O	O	O	O
A	a	O	O	O	O
40-year-old	40-year-old	O	O	O	O
woman	woman	O	O	O	O
with	with	O	O	O	O
major	major	O	DISEASE	OTHERS	I
depression	depression	O	DISEASE	OTHERS	I
took	took	O	O	O	O
an	an	O	O	O	O
overdose	overdose	O	DISEASE	OTHERS	I
of	of	O	O	O	O
venlafaxine	venlafaxine	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
an	an	O	O	O	O
apparent	apparent	O	O	O	O
suicide	suicide	O	O	O	O
attempt	attempt	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
the	the	O	O	O	O
ingestion	ingestion	O	O	O	O
of	of	O	O	O	O
26	26	O	O	O	O
venlafaxine	venlafaxine	CHEMICALS	O	OTHERS	I
50-mg	50-mg	O	O	O	O
tablets	tablets	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
experienced	experienced	O	O	O	O
a	a	O	O	O	O
witnessed	witnessed	O	O	O	O
generalized	generalized	O	O	O	O
seizure	seizure	O	DISEASE	OTHERS	I
.	.	O	O	O	O

She	she	O	O	O	O
was	was	O	O	O	O
admitted	admitted	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
medical	medical	O	O	O	O
intensive	intensive	O	O	O	O
care	care	O	O	O	O
unit	unit	O	O	O	O
,	,	O	O	O	O
venlafaxine	venlafaxine	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
discontinued	discontinued	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
no	no	O	O	O	O
further	further	O	O	O	O
sequelae	sequelae	O	O	O	O
were	were	O	O	O	O
seen	seen	O	O	O	O
.	.	O	O	O	O

DISCUSSION	discussion	O	O	O	O
:	:	O	O	O	O
To	to	O	O	O	O
our	our	O	O	O	O
knowledge	knowledge	O	O	O	O
,	,	O	O	O	O
this	this	O	O	O	O
is	is	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
reported	reported	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
venlafaxine	venlafaxine	CHEMICALS	O	OTHERS	I
overdose	overdose	O	DISEASE	OTHERS	I
that	that	O	O	O	O
resulted	resulted	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
generalized	generalized	O	O	O	O
seizure	seizure	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Based	based	O	O	O	O
on	on	O	O	O	O
nonoverdose	nonoverdose	O	O	O	O
pharmacokinetics	pharmacokinetics	O	O	O	O
and	and	O	O	O	O
pharmacodynamics	pharmacodynamics	O	O	O	O
of	of	O	O	O	O
venlafaxine	venlafaxine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
the	the	O	O	O	O
potential	potential	O	O	O	O
risks	risks	O	O	O	O
of	of	O	O	O	O
available	available	O	O	O	O
interventions	interventions	O	O	O	O
,	,	O	O	O	O
no	no	O	O	O	O
emergent	emergent	O	O	O	O
therapy	therapy	O	O	O	O
was	was	O	O	O	O
instituted	instituted	O	O	O	O
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
venlafaxine	venlafaxine	CHEMICALS	O	OTHERS	I
overdose	overdose	O	DISEASE	OTHERS	I
in	in	O	O	O	O
our	our	O	O	O	O
patient	patient	O	O	O	O
resulted	resulted	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
single	single	O	O	O	O
episode	episode	O	O	O	O
of	of	O	O	O	O
generalized	generalized	O	O	O	O
seizure	seizure	O	DISEASE	OTHERS	I
but	but	O	O	O	O
elicited	elicited	O	O	O	O
no	no	O	O	O	O
further	further	O	O	O	O
sequelae	sequelae	O	O	O	O
.	.	O	O	O	O

